5-1285859-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_198253.3(TERT):c.1574-3235G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 151,526 control chromosomes in the GnomAD database, including 6,736 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.29 ( 6736 hom., cov: 29)
Consequence
TERT
NM_198253.3 intron
NM_198253.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.498
Publications
114 publications found
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
- pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dyskeratosis congenita, autosomal dominant 2Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
- acute myeloid leukemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma, cutaneous malignant, susceptibility to, 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 5-1285859-C-A is Benign according to our data. Variant chr5-1285859-C-A is described in ClinVar as Benign. ClinVar VariationId is 539227.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TERT | NM_198253.3 | c.1574-3235G>T | intron_variant | Intron 2 of 15 | ENST00000310581.10 | NP_937983.2 | ||
| TERT | NM_001193376.3 | c.1574-3235G>T | intron_variant | Intron 2 of 14 | NP_001180305.1 | |||
| TERT | NR_149162.3 | n.1653-3235G>T | intron_variant | Intron 2 of 12 | ||||
| TERT | NR_149163.3 | n.1653-3235G>T | intron_variant | Intron 2 of 12 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TERT | ENST00000310581.10 | c.1574-3235G>T | intron_variant | Intron 2 of 15 | 1 | NM_198253.3 | ENSP00000309572.5 | |||
| TERT | ENST00000334602.10 | c.1574-3235G>T | intron_variant | Intron 2 of 14 | 1 | ENSP00000334346.6 | ||||
| TERT | ENST00000460137.6 | n.1574-3235G>T | intron_variant | Intron 2 of 12 | 1 | ENSP00000425003.1 | ||||
| TERT | ENST00000656021.1 | n.*1119+306G>T | intron_variant | Intron 3 of 16 | ENSP00000499759.1 |
Frequencies
GnomAD3 genomes AF: 0.292 AC: 44209AN: 151408Hom.: 6729 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
44209
AN:
151408
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.292 AC: 44226AN: 151526Hom.: 6736 Cov.: 29 AF XY: 0.291 AC XY: 21553AN XY: 74004 show subpopulations
GnomAD4 genome
AF:
AC:
44226
AN:
151526
Hom.:
Cov.:
29
AF XY:
AC XY:
21553
AN XY:
74004
show subpopulations
African (AFR)
AF:
AC:
7734
AN:
41326
American (AMR)
AF:
AC:
4243
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
AC:
1312
AN:
3460
East Asian (EAS)
AF:
AC:
1996
AN:
5094
South Asian (SAS)
AF:
AC:
2024
AN:
4794
European-Finnish (FIN)
AF:
AC:
3275
AN:
10468
Middle Eastern (MID)
AF:
AC:
133
AN:
292
European-Non Finnish (NFE)
AF:
AC:
22477
AN:
67874
Other (OTH)
AF:
AC:
749
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1514
3028
4542
6056
7570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1512
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.